The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Mechanisms linking obesity with cardiovascular disease
Abstract
Obesity increases the risk of cardiovascular disease and premature death. Adipose tissue releases a large number of bioactive mediators that influence not only body weight homeostasis but also insulin resistance - the core feature of type 2 diabetes - as well as alterations in lipids, blood pressure, coagulation, fibrinolysis and inflammation, leading to endothelial dysfunction and atherosclerosis. We are now beginning to understand the underlying mechanisms as well as the ways in which smoking and dyslipidaemia increase, and physical activity attenuates, the adverse effects of obesity on cardiovascular health.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity is strongly associated with the development of major risk factors for atherosclerotic disease such as hypertension, hyperlipidemia, and diabetes (79, 89, 358).”
From Cardiac remodeling in obesity (2008) · cites this paper as [358]
In the citing paper
“In addition, endothelial dysfunction is widely present in obesity and the metabolic syndrome (84, 325, 358).”
From Cardiac remodeling in obesity (2008) · cites this paper as [358]
In the citing paper
“In other populations, such as those in the STRONG heart study (native Americans of the western United States) and the Framingham heart study, diabetes or the metabolic syndrome do appear to be significant risk factors for LV hypertrophy (272, 306, 358).”
From Cardiac remodeling in obesity (2008) · cites this paper as [358]
Citations
Cites
1 retracted
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
RetractedYusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Berenson, G. S., Srinivasan, S. R., Bao, W., Newman, W. P., Tracy, R. E., & Wattigney, W. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382302 · Cited by 4,032
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Yusuf, S., Hawken, S., Ôunpuu, S., Bautista, L., Franzosi, M. G., Commerford, P., Lang, C. C., Rumboldt, Z., Onen, C. L., Lisheng, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67663-5 · Cited by 2,903
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612
Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old
Adams, K. F., Schatzkin, A. G., Harris, T. B., Kipnis, V., Mouw, T., Ballard-Barbash, R. R., Hollenbeck, A. R., & Leitzmann, M. F. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055643 · Cited by 2,147
Cited by
Sorted by citations
Items 101–200 of 1,009
Vaidya, J. S., Bulsara, M. K., Baum, M., Wenz, F. K., Massarut, S., Pigorsch, S. U., Alvarado, M. D., Douek, M., Saunders, C. M., Flyger, H. L., et al. (2020) · BMJ · doi:10.1136/bmj.m2836 · Cited by 292
DNA damage response and metabolic disease
Shimizu, I., Yoshida, Y., Suda, M., & Minamino, T. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.008 · Cited by 286
Inflammatory lipid mediators in adipocyte function and obesity
Iyer, A., Fairlie, D. P., Prins, J. B., Hammock, B. D., & Brown, L. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.264 · Cited by 290
Hahad, O., Prochaska, J. H., Daiber, A., & Münzel, T. F. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4623109 · Cited by 300
Wang, S., Liang, X., Yang, Q., Fu, X., Rogers, C. J., Zhu, M. J., Rodgers, B. D., Jiang, Q., Dodson, M. V., & Du, . (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.23 · Cited by 285
“3,4 In contrast, BAT specializes in dissipating energy as heat due to its high mitochondrial content and expression of uncoupling protein 1 (UCP1).”
BackgroundDoes Inflammation Determine Metabolic Health Status in Obese and Nonobese Adults?
Phillips, C. M., & Perry, I. J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2038 · Cited by 286
Adipokines – removing road blocks to obesity and diabetes therapy
Blüher, M. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.01.005 · Cited by 273
“When adipose tissue inflammation and dysfunction have developed, adipokine secretion is significantly changed towards a diabetogenic, proinflammatory, and atherogenic pattern [1,2,9].”
BackgroundHoeck, V. V., Sturmey, R. G., Bermejo‐Álvarez, P., Rizos, D. V., Gutiérrez‐Adán, A., Leese, H. J., Bols, P. E. J., & Leroy, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023183 · Cited by 272
Oversecretion of interleukin-15 from skeletal muscle reduces adiposity
Quinn, L. S., Anderson, B. G., Strait-Bodey, L., Stroud, A. M., & Argilés, J. M. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90506.2008 · Cited by 267
Appetite-Controlling Endocrine Systems in Teleosts
Rønnestad, I., Gomes, A. S., Murashita, K., Angotzi, A. R., Jönsson, E., & Volkoff, H. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00073 · Cited by 280
“Since obesity is linked to several comorbidities in humans, including type II diabetes and cardiovascular disease (244, 245), leptin has been extensively investigated in both humans and murine models.”
BackgroundRelationships between Obesity and Cardiovascular Diseases in Four Southern States and Colorado
Akil, L., & Ahmad, H. (2011) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2011.0166 · Cited by 265
Structural and functional changes in the kidneys of high-fat diet-induced obese mice
Deji, N., Kume, S., Araki, S., Soumura, M., Sugimoto, T., Isshiki, K., Chin‒Kanasaki, M., Sakaguchi, M., Koya, D., Haneda, M., et al. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00110.2008 · Cited by 263
Platelet activation in obesity and metabolic syndrome
Santilli, F., Vazzana, N., Liani, R., Guagnano, M. T., & Davı̀, G. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00930.x · Cited by 276
Shelton, R. C., & Miller, A. H. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.004 · Cited by 264
Garvey, W. T., Gaal, L. V., Leiter, L. A., Vijapurkar, U., List, J. F., Cuddihy, R. M., Ren, J., & Davies, M. J. (2018) · Metabolism · doi:10.1016/j.metabol.2018.02.002 · Cited by 269
Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety
Brooks, L. J., Viardot, A., Tsakmaki, A., Stolarczyk, É., Howard, J. K., Cani, P. D., Everard, A., Sleeth, M., Psichas, A., Anastasovskaj, J., et al. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.10.011 · Cited by 258
“Obesity is currently one of the most serious global threats to human health and an important 2 modifiable risk factor for type-2 diabetes, hypertension, and certain cancers [1-3].”
BackgroundPatel, V. B., Mori, J., McLean, B. A., Basu, R., Das, S. K., Ramprasath, T., Parajuli, N., Penninger, J. M., Grant, M. B., Lopaschuk, G. D., et al. (2015) · Diabetes · doi:10.2337/db15-0399 · Cited by 260
“Obesity is closely linked to cardiac steatosis and lipotoxicity, which are key pathogenic events in driving heart disease in obese states (26,34).”
BackgroundObesity and ageing: Two sides of the same coin
Tam, B. T., Morais, J. A., & Santosa, S. (2020) · Obesity Reviews · doi:10.1111/obr.12991 · Cited by 274
“linking obesity with CVD, readers are referred to previous studies.(194,195)”
BackgroundMethodEpicardial adipose tissue: far more than a fat depot.
Talman, A. H., Psaltis, P. J., Cameron, J. D., Meredith, I. T., SENEVIRATNE, S. K., & Wong, D. T. L. (2014) · PubMed · doi:10.3978/j.issn.2223-3652.2014.11.05 · Cited by 259
“There are many plausible mechanisms that could account for this, including changes in blood pressure, blood glucose regulation, lipid metabolism and overall systemic inflammation (3).”
BackgroundThe Impact of Obesity on Cardiovascular Disease Risk Factors and Subclinical Vascular Disease
Burke, G. L., Bertoni, A. G., Shea, S., Tracy, R. P., Watson, K. E., Blumenthal, R. S., Chung, H., & Carnethon, M. R. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.9.928 · Cited by 249
Obesity, DNA Damage, and Development of Obesity-Related Diseases
Włodarczyk, M., & Nowicka, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051146 · Cited by 257
“Obesity is well recognized to be involved in the development of diabetes and atherosclerosis-related diseases and to increase the mortality rate, particularly deaths from cardiovascular diseases [92].”
BackgroundMariappan, N., Elks, C. M., Sriramula, S., Guggilam, A., Liu, Z., Borkhsenious, O. N., & Francis, J. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp305 · Cited by 248
Dirinck, E. L., Jorens, P. G., Covaci, A., Geens, T., Roosens, L., Neels, H. M., Mertens, I. L., & Gaal, L. V. (2010) · Obesity · doi:10.1038/oby.2010.133 · Cited by 240
Self-citationPatel, T. P., Rawal, K., Bagchi, A. K., Akolkar, G., Bernardes, N., Dias, D. D. S., Gupta, S. S., & Singal, P. K. (2015) · Heart Failure Reviews · doi:10.1007/s10741-015-9515-6 · Cited by 243
Swarbrick, M. M., & Havel, P. J. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2007.0029 · Cited by 244
INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES
Baru, P. C. R. (2014) · ADVANCED SCIENCES INDEX · Cited by 236
Defining Metabolically Healthy Obesity: Role of Dietary and Lifestyle Factors
Phillips, C. M., Dillon, C. B., Harrington, J. M., Carthy, V. J. C. M., Kearney, P. M., Fitzgerald, T., & Perry, I. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076188 · Cited by 239
“Physical activity is associated with health-related benefits leading to lower risk of obesity, CVD and T2DM [41–43].”
Propionic acid affects immune status and metabolism in adipose tissue from overweight subjects
Al-Lahham, S., Roelofsen, H., Rezaee, F., Weening, D., Hoek, A., Vonk, R. J., & Venema, K. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02590.x · Cited by 241
“Propionic acid affects immune status and metabolism in adipose tissue from overweight subjects Sa’ad Al-Lahham *,† , Han Roelofsen † , Farhad Rezaee † , Desiree Weening † , Annemieke Hoek ‡ , Roel Vonk † and Koen Venema *,§”
Rossmeisl, M., Macek Jilkova, Z., Kuda, O., Jelenik, T., Medrikova, D., Stankova, B., Kristinsson, B., Haraldsson, G. G., Svensen, H., Stoknes, I., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038834 · Cited by 230
“components of the metabolic syndrome [1], are a major public health problem.”
BackgroundEpidemiology of Coronary Artery Disease
Duggan, J. P., Peters, A. S., Trachiotis, G. D., & Antevil, J. L. (2022) · Surgical Clinics of North America · doi:10.1016/j.suc.2022.01.007 · Cited by 266
The common inflammatory etiology of depression and cognitive impairment: a therapeutic target
Allison, D. J., & Ditor, D. S. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0151-1 · Cited by 245
“In addition, chronic inflammation contributes to the pathogenesis of a number of related metabolic disorders, and these disorders in turn have been shown to contribute to the elevated inflammatory state, creating a vicious cycle [4-8].”
BackgroundAbdulnour, J., Doucet, É., Brochu, M., Lavoie, J.-M., Strychar, I., Rabasa-Lhoret, R., & Prud’homme, D. (2012) · Menopause · doi:10.1097/gme.0b013e318240f6f3 · Cited by 229
“VF, in turn, is associated with metabolic complications such as insulin resistance (IR), dyslipidemia, type 2 diabetes, and metabolic syndrome.(5,6) Menopause has also been reported to be associated with a deleterious effect on plasma lipids, lipoproteins, and IR.”
BackgroundObstructive Sleep Apnea and Cardiovascular Disease
Pack, A. I., & Gislason, T. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.01.002 · Cited by 228
Overview of Adipose Tissue and Its Role in Obesity and Metabolic Disorders
Frühbeck, G. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-245-8_1 · Cited by 233
Lipid parameters for measuring risk of cardiovascular disease
Arsenault, B. J., Boekholdt, S. M., & Kastelein, J. J. P. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.223 · Cited by 234
Mutual Dependence of Foxo3a and PGC-1α in the Induction of Oxidative Stress Genes
Olmos, Y., Valle, I., Borniquel, S., Tiérrez, A., Soria, E., Lamas, S., & Monsalve, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807397200 · Cited by 229
Peng, H., Huang, J., Liu, X., Cheng, X., Xu, W., Zhao, C., Wei, F., & Zhang, Q. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b12358 · Cited by 228
Hermsdorff, H. H. M., Zulet, M. Á., Abete, I., & Martínez, J. A. (2011) · European Journal of Nutrition · doi:10.1007/s00394-010-0115-x · Cited by 223
Oberbach, A., Blüher, M., Loeffler‐Wirth, H., Till, H., Kovacs, P. L., Kullnick, Y., Schlichting, N. S., Tomm, J. M., Rolle-Kampczyk, U. E., Murugaiyan, J., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr2005555 · Cited by 220
Weight Management in Type 2 Diabetes: Current and Emerging Approaches to Treatment
Van Gaal, L., & Scheen, A. (2015) · Diabetes Care · doi:10.2337/dc14-1630 · Cited by 221
“Obesitydin particular abdominal obesitydis a major driver in the development of diabetes and cardiovascular disease (2), with the increasing prevalence of obesity mirrored by the rising prevalence of diabetes (3).”
BackgroundAn Integrated View of Insulin Resistance and Endothelial Dysfunction
Muniyappa, R., Iantorno, M., & Quon, M. J. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.06.001 · Cited by 227
Periadventitial Adipose Tissue Plays a Critical Role in Vascular Remodeling
Takaoka, M., Nagata, D., Kihara, S., Shimomura, I., Kimura, Y., Tabata, Y., Saito, Y., Nagai, R., & Sata, M. (2009) · Circulation Research · doi:10.1161/circresaha.109.199653 · Cited by 217
Patel, V. B., Shah, S., Verma, S., & Oudit, G. Y. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9644-1 · Cited by 218
Links Between Ectopic Fat and Vascular Disease in Humans
Lim, S. K., & Meigs, J. B. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303035 · Cited by 224
Combating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity
Pagnotti, G. M., Styner, M., Uzer, G., Patel, V. S., Wright, L. E., Ness, K. K., Guise, T. A., Rubin, J. E., & Rubin, C. T. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0170-1 · Cited by 218
Plant-Based Dietary Patterns for Human and Planetary Health
Gibbs, J. G., & Cappuccio, F. P. (2022) · Nutrients · doi:10.3390/nu14081614 · Cited by 278
Copper regulates cyclic-AMP-dependent lipolysis
Krishnamoorthy, L., Cotruvo, J. A., Chan, J., Kaluarachchi, H., Muchenditsi, A., Pendyala, V. S., Jia, S., Aron, A. T., Ackerman, C. M., Wal, M. N. V., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2098 · Cited by 228
Body Mass Index Predicts Aldosterone Production in Normotensive Adults on a High-Salt Diet
Bentley–Lewis, R., Adler, G. K., Perlstein, T. S., Seely, E. W., Hopkins, P. N., Williams, G. H., & Garg, R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1088 · Cited by 213
An update on physical health and economic consequences of overweight and obesity
Chu, D., Nguyệt, N. T. M., Dinh, T. C., Lien, N. V. T., Nguyen, K. H., Ngọc, V. T. N., Tao, Y., Sơn, L. H., Le, D., Nga, V. B., et al. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.05.004 · Cited by 228
“risk of coronary heart disease (CHD) in obese patients is higher than that in healthy ones [20].”
BackgroundInfluence of Adiposity and Physical Activity on Arterial Stiffness in Healthy Children
Sakuragi, S., Abhayaratna, K., Gravenmaker, K. J., O’Reilly, C. M., Srikusalanukul, W., Budge, M. M., Telford, R. D., & Abhayaratna, W. P. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.123364 · Cited by 212
Doumouras, A. G., Wong, J. A., Paterson, J. M., Lee, Y., Sivapathasundaram, B., Tarride, J.-E., Thabane, L., Hong, D., Yusuf, S., & Anvari, M. (2021) · Circulation · doi:10.1161/circulationaha.120.052386 · Cited by 209
Zhou, M.-S., Schulman, I. H., & Zeng, Q. (2012) · Vascular Medicine · doi:10.1177/1358863x12450094 · Cited by 214
Metabolic syndrome as a risk factor for neurological disorders
Farooqui, A. A., Farooqui, T., Panza, F., & Frisardi, V. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0840-1 · Cited by 213
Proinflammatory Cytokines in Obesity: Impact of Type 2 Diabetes Mellitus and Gastric Bypass
Catalán, V., Gómez‐Ambrosi, J., Ramírez, B., Rotellar, F., Pastor, C., Silva, C., Rodríguez, A., Gil, M. J., Cienfuegos, J. A., & Frühbeck, G. (2007) · Obesity Surgery · doi:10.1007/s11695-008-9424-z · Cited by 212
Nutritionally Mediated Oxidative Stress and Inflammation
Muñoz, A. B., & Costa, M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/610950 · Cited by 215
Farzaneh-Far, R., Lin, J., Epel, E., Lapham, K., Blackburn, E., & Whooley, M. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008612 · Cited by 203
Maessen, M. F. H., Eijsvogels, T. M. H., Verheggen, R. J. H. M., Hopman, M. T. E., Verbeek, A. L. M., & Vegt, F. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107212 · Cited by 203
Clinical Relevance of Adipokines
Blüher, M. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.5.317 · Cited by 210
“Adipose tissue inflammation and dysfunction Adipose tissue dysfunction and ectopic fat accumulation belong to the early abnormalities in the development of obesity and seem to be important factors determining the individual risk to develop metabolic and cardiovascular comorbidities of obesity [1,3-6].”
BackgroundInfluentialPerinatal high fat diet alters glucocorticoid signaling and anxiety behavior in adulthood
Sasaki, A., de Vega, W. C., St-Cyr, S., Pan, P., & McGowan, P. O. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.02.044 · Cited by 194
“Exposure to a diet high in fat during development is a well known risk factor for coronary heart disease, type 2 diabetes and the metabolic syndrome in adulthood (Marx, 2002; Boksa, 2004; Kahn et al., 2006; Van Gaal et al., 2006; Peleg-Raibstein et al., 2012).”
BackgroundNonalcoholic fatty liver disease and vascular disease: State-of-the-art
Fargion, S. R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i37.13306 · Cited by 202
Low-grade inflammation and its relation to obesity and chronic degenerative diseases
Castro, A. M., la Concha, L. E. M.-D., & Pantoja-Melendez, C. A. (2016) · Revista Médica Del Hospital General De México · doi:10.1016/j.hgmx.2016.06.011 · Cited by 209
“In obesity-related proinflammatory states, the increased size of adipocytes plays a decisive role, because, to the extent that it increases adipose tissue, the production of adipocytokines increases, and this triggers a series of inflammation-related pathophysiological processes.(12) One of the processes involved in i…”
BackgroundI Diretriz sobre o consumo de Gorduras e Saúde Cardiovascular
Santos, R., Gagliardi, A., Xavier, H. T., Magnoni, C., Cassani, R., Lottenberg, A., Filho, A. C., Araújo, D., Cesena, F., Alves, R., et al. (2013) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.2013s003 · Cited by 211
Vaspin in obesity and diabetes: pathophysiological and clinical significance
Blüher, M. (2011) · Endocrine · doi:10.1007/s12020-011-9572-0 · Cited by 195
MR imaging of adventitial vasa vasorum in carotid atherosclerosis
Kerwin, W., Oikawa, M., Yuan, C., Jarvik, G. P., & Hatsukami, T. S. (2008) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21532 · Cited by 193
Catalán, V., Gómez‐Ambrosi, J., Rodrı́guez, A., Ramírez, B., Silva, C., Rotellar, F., Gil, M. J. C., Cienfuegos, J. A., Salvador, J., & Frühbeck, G. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0486-8 · Cited by 190
Nonalcoholic fatty liver disease is associated with cognitive function in adults
Seo, S. W., Gottesman, R. F., Clark, J. M., Hernáez, R., Chang, Y., Kim, C., Ha, K. H., Güallar, E., & Lazo, M. (2016) · Neurology · doi:10.1212/wnl.0000000000002498 · Cited by 192
Dietary whey protein lessens several risk factors for metabolic diseases: a review
Sousa, G. T., Lira, F. S., Neto, J. C. R., de Oliveira, E. P., Oyama, L. M., dos Santos, R. V. T., & Pimentel, G. D. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-67 · Cited by 191
“Collectively, these findings suggest that whey protein may act as a nutritional component to increase endogenous antioxidant enzymes (glutathione peroxidase, catalase, and superoxide dismutase) and to reduce oxidative stress markers (MDA, TBARS) jointly with low expression of pro-inflammatory cytokines (IL-1β, IL-6 an…”
BackgroundInfluentialCombating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes
Scheen, A. J., & Gaal, L. F. V. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70004-x · Cited by 193
Xie, Z., Wang, X., Liu, X., Du, H., Sun, C., Shao, X., Tian, J., Gu, X., Wang, H., Tian, J., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007442 · Cited by 194
“O besity is a well-established risk factor for atherosclerosis.(1) Individuals with excess deposition of adipose tissue (AT) exhibit increased coronary plaque vulnerability and coronary plaque progression as well as high cardiovascular event rates.”
BackgroundVitamin D and adipose tissue—more than storage
Mutt, S. J., Hyppönen, E., Saarnio, J., Järvelin, M., & Herzig, K. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00228 · Cited by 197
“Excess in adipose tissue has been attributed to a variety of diseases including cancer, diabetes, cardiovascular and neurodegenerative diseases and decrease in life expectancy (Adams et al., 2006; Despres and Lemieux, 2006; Kahn et al., 2006; Van Gaal et al., 2006).”
BackgroundInflammatory cause of metabolic syndrome via brain stress and NF-κB
Cai, D., & Liu, T. (2012) · Aging · doi:10.18632/aging.100431 · Cited by 192
Marrelli, M., Amodeo, V., Statti, G. A., & Conforti, F. (2018) · Molecules · doi:10.3390/molecules24010119 · Cited by 190
“In obese patients, a variety of morphological adaptations in cardiac structure and hemodynamic function may be observed [104].”
BackgroundAmen, O. M., Sarker, S. D., Ghildyal, R., & Arya, A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00977 · Cited by 190
Air pollution and gene-specific methylation in the Normative Aging Study
Bind, M., Lepeule, J., Zanobetti, A., Gasparrini, A., Baccarelli, A., Coull, B. A., Tarantini, L., Vokonas, P., Koutrakis, P., & Schwartz, J. D. (2014) · Epigenetics · doi:10.4161/epi.27584 · Cited by 187
Kim, E., Choi, J., Yu, M.-R., Kim, M.-Y., Lee, S., & Lee, B. (2012) · Korean Journal of Food Science and Technology · doi:10.9721/kjfst.2012.44.3.337 · Cited by 184
de Mello, V. D., Lankinen, M. A., Schwab, U., Kolehmainen, M., Lehto, S., Seppänen‐Laakso, T., Orešič, M., Pulkkinen, L., Uusitupa, M. I. J., & Erkkilä, A. T. (2009) · Diabetologia · doi:10.1007/s00125-009-1482-9 · Cited by 182
McCrimmon, R. J., Catarig, A.-M., Frias, J. P., Lausvig, N. L., le Roux, C. W., Thielke, D., & Lingvay, I. (2020) · Diabetologia · doi:10.1007/s00125-019-05065-8 · Cited by 184
“Abdominal obesity is a key factor in the development of diabetes and cardiovascular disease [30] and is a risk factor for several chronic diseases with cardiometabolic homeostasis [31].”
BackgroundQiao, T., Luo, T., Pei, H., Yimingniyazi, B., Aili, D., Aimudula, A., Zhao, H., Zhang, H., Dai, J., & Wang, D. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01670-x · Cited by 183
Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: Lessons from Type 1 Diabetes
Funk, S. D., Yurdagul, A., & Orr, A. W. (2012) · International Journal of Vascular Medicine · doi:10.1155/2012/569654 · Cited by 176
“Obesity, particularly abdominal obesity, results in enhanced expression of systemic circulating proinflammatory cytokines expression and reduced levels of protective factors such as adiponectin [30, 31].”
BackgroundLee, M.-W., Lee, M., & Oh, K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060854 · Cited by 192
Smoking, Central Adiposity, and Poor Glycemic Control Increase Risk of Hearing Impairment
Cruickshanks, K. J., Nondahl, D. M., Dalton, D. S., Fischer, M., Klein, R., Klein, R., Nieto, F. J., Schubert, C. R., & Tweed, T. S. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13401 · Cited by 175
“Waist circumference, which measures central fat distribution, may be an important risk marker for chronic diseases of aging because of associations with dyslipidemia, insulin resistance, and inflammation.(43) High levels of GHb, but not diagnosis of diabetes mellitus, were associated with greater risk of HI.”
BackgroundIdentification of Obesity and Cardiovascular Risk in Ethnically and Racially Diverse Populations
Rao, G., Powell‐Wiley, T. M., Ancheta, I. B., Hairston, K. G., Kirley, K., Lear, S. A., North, K. E., Palaniappan, L. P., & Rosal, M. C. (2015) · Circulation · doi:10.1161/cir.0000000000000223 · Cited by 180
“VAT likely serves as the site of dysfunctional, hypertrophic adipocytes that promote inflammation, oxidative stress, and production of cytokines and adipokines.(19,20) Consistent with the evidence of its metabolic activity, VAT has also been shown to predict CVD burden and incident cardiovascular events independent of…”
BackgroundPuchau, B., Zulet, M. Á., de Echávarri, A. G., Hermsdorff, H. H. M., & Martínez, J. A. (2009) · Nutrition · doi:10.1016/j.nut.2009.06.017 · Cited by 173
Hou, X., Lu, J., Weng, J., Ji, L., Shan, Z., Liu, J., Tian, H., Ji, Q., Zhu, D., Ge, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057319 · Cited by 174
Low-Grade Inflammation, Obesity, and Insulin Resistance in Adolescents
Herder, C., Schneitler, S., Rathmann, W., Haastert, B., Schneitler, H., Winkler, H., Bredahl, R., Hahnloser, E., & Martin, S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0955 · Cited by 176
Dhabhar, F. S. (2009) · Integrative and Comparative Biology · doi:10.1093/icb/icp045 · Cited by 179
Tang, Z.-Z., Chen, G., Hong, Q., Huang, S., Smith, H., Shah, R. D., Scholz, M. B., & Ferguson, J. F. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00454 · Cited by 175
“We measured plasma CRP, as a clinically-relevant marker of inflammation, which predicts future disease risk (Ridker, 2003), and used BMI as a proxy for obesity and future metabolic risk (Van Gaal et al., 2006).”
MethodYamakado, M., Nagao, K., Imaizumi, A., Tani, M., Toda, A., Tanaka, T., Jinzu, H., Miyano, H., Yamamoto, H., Daimon, T., et al. (2015) · Scientific Reports · doi:10.1038/srep11918 · Cited by 170
‘Metabolically healthy obesity’: Origins and implications
Denis, G. V., & Obin, M. S. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.004 · Cited by 176
Karastergiou, K., Evans, I. M., Ogston, N., Miheisi, N., Nair, D. R., Kaski, J. C., Jahangiri, M., & Mohamed‐Ali, V. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.204719 · Cited by 172
Henning, R. J. (2021) · Europe PMC (PubMed Central) · Cited by 209
Maternal high-fat diet in mice programs emotional behavior in adulthood
Peleg-Raibstein, D., Luca, E., & Wolfrum, C. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.05.027 · Cited by 167
Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids
Orešič, M., Hyötyläinen, T., Kotronen, A., Gopalacharyulu, P. V., Nygrén, H., Arola, J. T., Castillo, S., Mattila, I. M., Hakkarainen, A., Borra, R., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2981-2 · Cited by 173
“NAFLD predicts non-alcoholic steatohepatitis (NASH), type 2 diabetes and cardiovascular disease, independent of obesity [3–5].”
BackgroundSalgado‐Somoza, A., Teijeira‐Fernández, E., Fernández, Á. L., González‐Juanatey, J. R., & Eirás, S. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00120.2010 · Cited by 167
Zeng, C., Zhong, P., Zhao, Y., Kanchana, K., Zhang, Y., Khan, Z. A., Chakrabarti, S., Wu, L., Wang, J., & Liang, G. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.10.002 · Cited by 167
“[27].”
García‐García, I., Michaud, A., Dadar, M., Zeighami, Y., Neseliler, S., Collins, D. L., Evans, A. C., & Dagher, A. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0164-4 · Cited by 167
A systematic review on use of Chinese medicine and acupuncture for treatment of obesity
Sui, Y., Zhao, H., Wong, V. C. W., Brown, N., Li, X. L., Kwan, A. K. L., Hui, H., Ziea, E. T. C., & Chan, J. C. N. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00979.x · Cited by 166
Eriksson, J. W. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.06.044 · Cited by 176
Vaspin inhibits kallikrein 7 by serpin mechanism
Heiker, J. T., Klöting, N., Kovacs, P. L., Kuettner, E. B., Sträter, N., Schultz, S., Kern, M., Stümvoll, M., Blüher, M., & Beck‐Sickinger, A. G. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1258-8 · Cited by 166
“Obesity significantly increases the risk of developing type 2 diabetes mellitus, hypertension, coronary heart disease, stroke and several types of cancer [3].”
BackgroundEndovascular Injury Induces Rapid Phenotypic Changes in Perivascular Adipose Tissue
Takaoka, M., Suzuki, H., Shioda, S., Sekikawa, K., Saito, Y., Nagai, R., & Sata, M. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.207175 · Cited by 166
Metadata
- Authors
- Van Gaal, L. F., Mertens, I. L., & De Block, C. E.
- Affiliations
- University of Antwerp (BE)
- Venue
- Nature
- Published
- 2006-12
- Volume
- 444
- Issue
- 7121
- Pages
- 875-880
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1964607854
- Cited by
- 2,814
- References
- 86
- Citations by year
- 2026: 64 · 2025: 97 · 2024: 126 · 2023: 137 · 2022: 151 · 2021: 172 · 2020: 179 · 2019: 204 · 2018: 172 · 2017: 173 · 2016: 168 · 2015: 193 · 2014: 194 · 2013: 152 · 2012: 128
- FWCI
- 11.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- obesity, cardiovascular disease, adipose tissue, adipokines, insulin resistance, type 2 diabetes, dyslipidemia, blood pressure, coagulation, fibrinolysis, inflammation, endothelial dysfunction, atherosclerosis, smoking, physical activity, premature mortality
- MeSH terms
- Cardiovascular Diseases, Endothelium, Vascular, Humans, Insulin Resistance, Obesity, Oxidative Stress, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review